Cytosorbents Corporation
CTSO
$1.10
-$0.03-2.66%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.67M | -25.53M | -27.54M | -28.51M | -23.44M |
| Total Depreciation and Amortization | 2.11M | 2.15M | 2.16M | 2.03M | 1.51M |
| Total Amortization of Deferred Charges | 190.40K | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 660.60K | 6.04M | 4.37M | 2.46M | 800.30K |
| Change in Net Operating Assets | -2.79M | -3.89M | -2.36M | 2.36M | 537.50K |
| Cash from Operations | -18.49M | -21.24M | -23.38M | -21.66M | -20.59M |
| Capital Expenditure | -310.60K | -301.30K | -73.70K | -538.20K | -656.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -370.40K | -339.10K | -306.70K | -398.10K | -350.30K |
| Cash from Investing | -681.20K | -640.50K | -380.30K | -936.20K | -1.01M |
| Total Debt Issued | 15.00M | 15.00M | -- | -- | 5.00M |
| Total Debt Repaid | -5.00M | -5.00M | -625.00K | -- | -- |
| Issuance of Common Stock | 12.26M | 12.91M | 13.84M | 14.47M | 2.26M |
| Repurchase of Common Stock | -41.50K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -848.00K | -790.40K | -- | -- | 0.00 |
| Cash from Financing | 21.37M | 22.12M | 13.22M | 14.47M | 7.26M |
| Foreign Exchange rate Adjustments | -77.40K | -139.50K | -104.70K | -99.80K | 137.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.12M | 103.60K | -10.64M | -8.22M | -14.19M |
